Skip to main content

Bio-Rad and Integrated DNA Technologies to Co-Develop RNAi Tools

NEW YORK (GenomeWeb News) - Bio-Rad Laboratories and Integrated DNA Technologies plan to co-develop RNAi tool sets, Bio-Rad said today.

 
The companies will deliver IDT's Dicer-Substrate 27-mer siRNA duplexes for RNAi applications. Under the agreement, Bio-Rad will experimentally validate Dicer-Substrate siRNA duplexes in live cells.
 
Bio-Rad has exclusive rights to sell the Dicer-Substrate siRNAs that it tests and validates.
 
Bio-Rad and IDT also plan to develop a series of control kits for use with IDT's TriFECTa Dicer-Substrate RNAi kits and Bio-Rad's validated siRNA duplexes.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.